Literature DB >> 18420479

Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts.

Minna Pekkinen1, Mikael E B Ahlström2, Ulrike Riehle3, Minna M Huttunen2, Christel J E Lamberg-Allardt2.   

Abstract

The second messenger molecule cyclic adenosine monophosphate (cAMP) plays an important role in the hormonal regulation of bone metabolism. cAMP is inactivated by the cyclic nucleotide phosphodiesterases (PDEs), a superfamily of enzymes divided into 11 known families designated PDE 1-11. The aim of this study was to investigate the effect of PDE7 and PDE8 inhibition on the gene expression and differentiation of human osteoblasts. Osteoblasts differentiated from human mesenchymal stem cells (hMSC) were cultured and treated with short interfering RNAs (siRNAs) generated from PDE7 and PDE8 PCR products. Total RNA was isolated from the cells, and gene expression was assayed with cDNA microarray and quantitative real-time PCR. bALP measurements were assayed during differentiation, and mineralization was determined by quantitative Alizarin red S staining. PDE7 and PDE8 inhibition by RNA interference decreased the gene expression of PDE7A by 60-70%, PDE7B by 40-50%, and PDE8A by 30%. PDE7 silencing increased the expression of beta-catenin, osteocalcin, caspase-8, and cAMP-responsive element-binding protein 5 (CREB-5) genes and decreased the expression of the 1, 25-dihydroxyvitamin D3 receptor gene. PDE8A silencing increased the expression of anti-apoptotic genes, but decreased the expression of osteoglycin (osteoinductive factor) and bone morphogenetic protein 1 (BMP-1). PDE7 silencing increased bALP and mineralization up to three-fold compared to controls. Treatment with the PDE7-selective PDE inhibitor BRL-50481 had similar effects on mineralization as the gene silencing. The PDE7 silencing also increased forskolin stimulated cAMP response, but had no effect on the proliferation rate. Furthermore, osteocalcin expression was increased by PDE7 silencing by a mechanism dependent on protein kinase A. Our results show that specific gene silencing with the RNAi method is a useful tool for inhibiting the gene expression of specific PDEs and that PDE7 silencing upregulates several osteogenic genes and increases mineralization. PDE7 may play an important role in the regulation of osteoblastic differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420479     DOI: 10.1016/j.bone.2008.02.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells.

Authors:  Kye-Im Jeon; Hirofumi Jono; Clint L Miller; Yujun Cai; Soyeon Lim; Xuan Liu; Pingjin Gao; Jun-Ichi Abe; Jian-Dong Li; Chen Yan
Journal:  FEBS J       Date:  2010-11-16       Impact factor: 5.542

Review 2.  Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Authors:  Kalpana Mujoo; Joshua S Krumenacker; Ferid Murad
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

Review 3.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

4.  Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells.

Authors:  Husnain Kh Haider; Yun-Jung Lee; Shujia Jiang; Rafeeq P H Ahmed; Mok Ryon; Muhammad Ashraf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

5.  Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.

Authors:  Lingzhi Zhang; Fiona Murray; Anja Zahno; Joan R Kanter; Daisy Chou; Ryan Suda; Michael Fenlon; Laura Rassenti; Howard Cottam; Thomas J Kipps; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

6.  Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts.

Authors:  Rongrong Zhang; James R Edwards; Seon-Yle Ko; Shanshan Dong; Hongbin Liu; Babatunde O Oyajobi; Christopher Papasian; Hong-Wen Deng; Ming Zhao
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

Review 7.  Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity.

Authors:  Marcella Brescia; Manuela Zaccolo
Journal:  Int J Mol Sci       Date:  2016-10-02       Impact factor: 5.923

8.  Role of LncRNA score and PVT1 in primary hyperparathyroidism-- a preliminary study.

Authors:  Dongxue Zhang; Bojun Wei; Long Li; Tao Jiang; Xiaoai Yao; Xin Liu; Yuyan Sun
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-04-28

9.  PDE7B is involved in nandrolone decanoate hydrolysis in liver cytosol and its transcription is up-regulated by androgens in HepG2.

Authors:  Emmanuel Strahm; Anders Rane; Lena Ekström
Journal:  Front Pharmacol       Date:  2014-05-30       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.